Annals

Special Issue: Myasthenia Gravis and Related Disorders I (vol 1412)

Edited by

Ann NY Acad Sci editorial staff

Explore the Table of Contents
Special Issue: Myasthenia Gravis and Related Disorders I (vol 1412)

Published: January 2018

Volume 1412

Published since 1824, Annals of the New York Academy of Sciences is the Academy’s premier scientific publication.

Learn More

COMMENTARY

Learning from the past: reflections on recently completed myasthenia gravis trials

Michael Benatar, James F. Howard Jr., Richard Barohn, Gil I. Wolfe, Gary Cutter

PERSPECTIVE

A unique subphenotype of myasthenia gravis

Jeannine M. Heckmann, Melissa Nel

CONCISE REVIEWS

AIRE: a missing link to explain female susceptibility to autoimmune diseases

Sonia Berrih‐Aknin, Rozen Le Panse, Nadine Dragin

Circulating microRNAs as potential biomarkers in myasthenia gravis patients

Anna Rostedt Punga, Tanel Punga

Age‐related changes in the structure and function of mammalian neuromuscular junctions

Silvia Willadt, Mark Nash, Clarke Slater

The mouse passive‐transfer model of MuSK myasthenia gravis: disrupted MuSK signaling causes synapse failure

Nazanin Ghazanfari, Sofie Trajanovska, Marco Morsch, Simon X. Liang, Stephen W. Reddel, William D. Phillips

The molecular cross talk of the dystrophin–glycoprotein complex

Marta Gawor, Tomasz J. Prószyński

Lambert–Eaton myasthenic syndrome: mouse passive‐transfer model illuminates disease pathology and facilitates testing therapeutic leads

Stephen D. Meriney, Tyler B. Tarr, Kristine S. Ojala, Man Wu, Yizhi Li, David Lacomis, Adolfo Garcia‐Ocaña, Mary Liang, Guillermo Valdomir, Peter Wipf

Myasthenia gravis with antibodies to MuSK: an update

Amelia Evoli, Paolo E. Alboini, Valentina Damato, Raffaele Iorio, Carlo Provenzano, Emanuela Bartoccioni, Mariapaola Marino

REVIEWS

Diagnostic utility of cortactin antibodies in myasthenia gravis

Isabel Illa, Elena Cortés‐Vicente, María Ángeles Martínez, Eduard Gallardo

Developing treatment guidelines for myasthenia gravis

Donald B. Sanders, Gil I. Wolfe, Pushpa Narayanaswami, the MGFA Task Force on MG Treatment Guidance

Clinical and research strategies for limb‐girdle congenital myasthenic syndromes

Emily O'Connor, Ana Töpf, René P. Zahedi, Sally Spendiff, Daniel Cox, Andreas Roos, Hanns Lochmüller

Myasthenia gravis: the role of complement at the neuromuscular junction

James F. Howard Jr.

Therapeutic strategies for congenital myasthenic syndromes

Manon Lee, David Beeson, Jacqueline Palace

Thymus involvement in early‐onset myasthenia gravis

Mélanie A. Cron, Solène Maillard, José Villegas, Frédérique Truffault, Muriel Sudres, Nadine Dragin, Sonia Berrih‐Aknin, Rozen Le Panse

Neuromuscular synapse electrophysiology in myasthenia gravis animal models

Jaap J. Plomp, Maartje G.M. Huijbers, Jan J.G.M. Verschuuren

Mechanisms underlying B cell immune dysregulation and autoantibody production in MuSK myasthenia gravis

Panos Stathopoulos, Aditya Kumar, Jason A. Vander Heiden, Elba Pascual‐Goñi, Richard J. Nowak, Kevin C. O'Connor

ORIGINAL ARTICLES

The Association of British Neurologists' myasthenia gravis guidelines

Jon Sussman, Maria E. Farrugia, Paul Maddison, Marguerite Hill, M. Isabel Leite, David Hilton‐Jones

Homeostatic synaptic plasticity at the neuromuscular junction in myasthenia gravis

Xueyong Wang, Mark M. Rich